Kinnate Biopharma Inc.: 25-NSE filed Apr 3, 2024

Form type

25-NSE

Filing date

Apr 3, 2024

Accession number

0001354457-24-000225

Filer

Kinnate Biopharma Inc. (CIK 1797768)